1AI
Click for more information
9.09% 1.0¢ algorae pharmaceuticals limited

Ann: Cash conservation and change of CEO , page-2

  1. SleepingWolf
    179 Posts.
    lightbulb Created with Sketch. 3
    clock Created with Sketch.
    23/12/08
    12:04
    Post #: 4632761
    Morning all.

    Interesting announcement - Dr Caspari was only made CEO on 29/07/08 and he's already stepping down.

    The listing on the OTCQX in the USA has been a bit of a fizzer - apart from when LCT gained approval for the NZ trials, the volume of shares traded has been bugger all.

    Russian results are to be released just around the corner including one patient who received the meduim dose so lets hope for some positive news.



    Cheers

    SW

    LCT Price at posting: 10.0¢ Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
SVL Silver Mines models five new calderas close to 396Moz Bowdens deposit
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
1.0¢ 		Change
-0.001(9.09%) 		Mkt cap ! $16.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $500 50K

Buyers (Bids)

No. Vol. Price($)
5 3533429 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 1744396 12
View Market Depth
Last trade - 13.34pm 28/06/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.